The Efficacy of EPA+DHA (SC401B) for Lowering Triglyceride Levels (≥ 500 mg/dL)

NCT01997268 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study never initiated. IND placed on Hold

Conditions

Severe Hypertriglyceridemia

Interventions

DRUG: Placebo
DRUG: SC401B 2 capsules
DRUG: SC401B 4 capsules
DRUG: SC401B 6 capsules

Sponsor

Sancilio and Company, Inc.